The Effectiveness and Safety of Glofitamab in Real-World Clinical Practice Among Chinese Adult Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Prospective, Observational, Multicenter Study
Clinical trial NCT06656234 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06656234
- Sponsor
- Ruijin Hospital
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-10-30
- Primary completion
- 2027-09-15
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.